CD79b-directed Antibody–Drug Conjugates
DBCAT005702Pharmacologic class
Antibody-drug conjugates in which the antibody portion is directed towards CD79b. A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of November 29, 2022
Which targets do CD79b-directed Antibody–Drug Conjugates share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account